Moshe Talpaz
0000-0003-3361-3981
2 papers found
Refreshing results…
MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis
Phase III MANIFEST-2: pelabresib + ruxolitinib vs placebo + ruxolitinib in JAK inhibitor treatment-naive myelofibrosis
Missing publications? Search for publications with a matching author name.